These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 29460257)

  • 1. A Novel Earwax Method to Measure Acute and Chronic Glucose Levels.
    Herane-Vives A; Espinoza S; Sandoval R; Ortega L; Alameda L; Young AH; Arnone D; Hayes A; Benöhr J
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33321856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication.
    Ikramov A; Mukhtarova S; Trigulova R; Alimova D; Abdullaeva S
    Front Endocrinol (Lausanne); 2024; 15():1305640. PubMed ID: 38638138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysglycemia and Abnormal Adiposity Drivers of Cardiometabolic-Based Chronic Disease in the Czech Population: Biological, Behavioral, and Cultural/Social Determinants of Health.
    Pavlovska I; Polcrova A; Mechanick JI; Brož J; Infante-Garcia MM; Nieto-Martínez R; Maranhao Neto GA; Kunzova S; Skladana M; Novotny JS; Pikhart H; Urbanová J; Stokin GB; Medina-Inojosa JR; Vysoky R; González-Rivas JP
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Management of Patients with Inadequately Controlled Type 2 Diabetes Admitted to Hospital: Titration Patterns and Frequency of Hypoglycemia as Results of a Prospective Observational Study (Hospital Study).
    Brož J; Janíčková Žďárská D; Urbanová J; Piťhová P; Doničová V; Pálová S; Pelechová B; Smržová A; Kvapil M
    Diabetes Ther; 2021 Jul; 12(7):1799-1808. PubMed ID: 34028699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of postprandial glucose control.
    Bell DS
    South Med J; 2001 Aug; 94(8):804-9. PubMed ID: 11549192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic.
    Žďárská DJ; Hill M; Kvapil M; Piťhová P; Brož J
    Diabetes Ther; 2018 Apr; 9(2):665-672. PubMed ID: 29460257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gliclazide dose escalation on postprandial hyperglycemia in type 2 diabetes mellitus: A prospective, open-label, case-controlled, dose-escalation study.
    Naidoo P; Virendra R; Layla M
    Curr Ther Res Clin Exp; 2006 Mar; 67(2):81-102. PubMed ID: 24678087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of fasting and 2 hours postprandial blood glucose in the control of patients with type 2 diabetes].
    García Nava RE; Rodríguez Moctezuma R; Munguía Miranda C; Hernández Santiago JL; Casas de la Torre E; Martínez Bermúdez M; Cabrera Ramírez RM
    Rev Invest Clin; 2003; 55(1):26-30. PubMed ID: 12708160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of fasting and postprandial and plasma glucose with hemoglobinA1c in diabetics.
    Haddadinezhad S; Ghazaleh N
    Int J Diabetes Dev Ctries; 2010 Jan; 30(1):8-10. PubMed ID: 20431799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
    Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
    Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.
    Aronoff SL
    Postgrad Med; 2017 Mar; 129(2):231-241. PubMed ID: 28118069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
    Monnier L; Colette C
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.